A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Astellas Pharma Inc
Mayo Clinic
Neonc Technologies, Inc.
Genmab
Ocellaris Pharma, Inc.
Inhibrx Biosciences, Inc
Tanabe Pharma America, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
NuCana plc
OncoC4, Inc.
Klus Pharma Inc.
Aprea Therapeutics
Sarcoma Oncology Research Center, LLC
RAPT Therapeutics, Inc.
Cybrexa Therapeutics
Salubris Biotherapeutics Inc
AstraZeneca
NextCure, Inc.
Evopoint Biosciences Inc.
Gritstone bio, Inc.
Fred Hutchinson Cancer Center
Nektar Therapeutics
Institut Bergonié
Rubius Therapeutics
Incyte Corporation
Genocea Biosciences, Inc.
Silverback Therapeutics
Incyte Corporation
Incyte Corporation
Eli Lilly and Company